880762-38-9

Upstream product

• 848836-58-8 2,2,2-trifluoro-1-(4-fluorophenyl)ethyl trifluoromethanesulfonate 
• 25683-09-4 3-(triphenylmethylthio)-alanine 
• 17556-41-1 2,2,2-trifluoro-1-(4-fluorophenyl)ethanol 
• 655-32-3 2,2,2-trifluoro-1-(4-fluorophenyl)ethanone 
• 890040-25-2 trifluoromethanesulfonic acid 2,2,2-trifluoro-1-(S)-phenylethyl ester 
• 2799-07-7 S-trityl-L-cysteine 
• 84877-47-4 trifluoromethanesulfonic acid 2,2,2-trifluoro-1(R)-phenylethyl ester 

Relevant academic research and scientific papers

SULFONYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.

HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.